Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - TOTAL LIABILITIES
Total Liabilities AKRO - Akero Therapeutics, Inc.
45 M
LAST VALUE
30.41%
2 YEAR CAGR
-18.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR